Voyager Therapeutics (NASDAQ:VYGR) outlined what CEO Al Sandrock described as three “pillars of value” for the year ahead during a discussion at Oppenheimer’s 36th Annual Life Science Conference, ...
SMBs have the same intelligence needs as enterprises. They need clarity, speed, and confidence in their data. The Voyager program and Mission Control Network allows us to deliver those capabilities.” ...
- Transformative year for tau in AD: VY1706 clinical entry and VY7523 clinical data anticipated H2 2026 - - Validating brain-targeted capsids in humans: expect two I.V.-delivered neuro gene therapies ...
LEXINGTON, Mass., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced it has decided to ...
Breaking the AI Hardware Barrier: Enterprise-Grade Intelligence for Every Business—Starting with the MSPs Who Serve Them SMBs have the same intelligence needs as enterprises. They need clarity, speed, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results